ORAMED PHARMACEUTICALS INC. Shares Outstanding (Cover Page)
ORAMED PHARMACEUTICALS INC. (ORMP) had Shares Outstanding (Cover Page) of 41.60 million shares as of 2026-08-10, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-10
- 2026-08-10: Entity Common Stock, Shares Outstanding 41.60M shares.
- 2026-05-19: Entity Common Stock, Shares Outstanding 40.93M shares.
- 2026-03-26: Entity Common Stock, Shares Outstanding 40.45M shares.
- 2025-11-12: Entity Common Stock, Shares Outstanding 39.80M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-10 | 41.60M shares 10-Q · filed 2026-08-10 |
| 2026-05-19 | 40.93M shares 10-Q · filed 2026-05-19 |
| 2026-03-26 | 40.45M shares 10-K · filed 2026-03-26 |
| 2025-11-12 | 39.80M shares 10-Q · filed 2025-11-13 |
| 2025-08-12 | 41.00M shares 10-Q · filed 2025-08-14 |
| 2025-05-14 | 40.85M shares 10-Q · filed 2025-05-15 |
| 2025-03-27 | 40.85M shares 10-K/A · filed 2025-07-16 |
| 2024-11-07 | 40.31M shares 10-Q · filed 2024-11-07 |
| 2024-08-13 | 40.77M shares 10-Q · filed 2024-08-14 |
| 2024-05-09 | 40.63M shares 10-Q · filed 2024-05-09 |
| 2024-03-06 | 40.52M shares 10-K · filed 2024-03-06 |
| 2023-11-09 | 40.34M shares 10-Q · filed 2023-11-09 |
| 2023-08-10 | 40.28M shares 10-Q · filed 2023-08-10 |
| 2023-05-11 | 40.03M shares 10-Q · filed 2023-05-11 |
| 2023-03-06 | 39.78M shares 10-K · filed 2023-03-06 |
| 2022-11-10 | 39.11M shares 10-Q · filed 2022-11-10 |
| 2022-08-10 | 38.83M shares 10-Q · filed 2022-08-10 |
| 2022-05-12 | 38.56M shares 10-Q · filed 2022-05-12 |
| 2022-03-30 | 38.56M shares 10-QT · filed 2022-03-30 |
| 2022-01-11 | 38.28M shares 10-Q · filed 2022-01-11 |
| 2021-11-24 | 38.09M shares 10-K · filed 2021-11-24 |
| 2021-07-14 | 32.51M shares 10-Q · filed 2021-07-14 |
| 2021-04-13 | 30.23M shares 10-Q · filed 2021-04-13 |
| 2021-01-14 | 26.66M shares 10-Q · filed 2021-01-14 |
| 2020-11-24 | 23.68M shares 10-K · filed 2020-11-24 |
| 2020-07-07 | 23.53M shares 10-Q · filed 2020-07-07 |
| 2020-04-05 | 23.09M shares 10-Q · filed 2020-04-06 |
| 2020-01-09 | 17.74M shares 10-Q · filed 2020-01-09 |
| 2019-11-26 | 17.40M shares 10-K · filed 2019-11-27 |
| 2019-07-09 | 17.38M shares 10-Q · filed 2019-07-10 |
| 2019-04-09 | 17.38M shares 10-Q · filed 2019-04-10 |
| 2019-01-11 | 17.38M shares 10-Q · filed 2019-01-14 |
| 2018-11-26 | 17.38M shares 10-K · filed 2018-11-28 |
| 2018-07-11 | 17.36M shares 10-Q · filed 2018-07-12 |
| 2018-04-06 | 14.44M shares 10-Q · filed 2018-04-09 |
| 2018-01-10 | 14.37M shares 10-Q · filed 2018-01-11 |
| 2017-11-28 | 14.31M shares 10-K · filed 2017-11-29 |
| 2017-07-04 | 13.32M shares 10-Q · filed 2017-07-06 |
| 2017-04-04 | 13.29M shares 10-Q · filed 2017-04-05 |
| 2017-01-10 | 13.28M shares 10-Q · filed 2017-01-11 |
| 2016-11-22 | 13.26M shares 10-K · filed 2016-11-25 |
| 2016-07-05 | 13.14M shares 10-Q · filed 2016-07-06 |
| 2016-04-05 | 13.12M shares 10-Q · filed 2016-04-06 |
| 2016-01-12 | 13.10M shares 10-Q · filed 2016-01-13 |
| 2015-11-24 | 11.60M shares 10-K · filed 2015-11-25 |
| 2015-06-30 | 11.55M shares 10-Q · filed 2015-07-01 |
| 2015-03-31 | 10.82M shares 10-Q · filed 2015-04-03 |
| 2015-01-06 | 10.83M shares 10-Q · filed 2015-01-08 |
| 2014-11-12 | 10.11M shares 10-K · filed 2014-11-14 |
| 2014-07-11 | 9.96M shares 10-Q · filed 2014-07-14 |
| 2014-04-08 | 9.94M shares 10-Q · filed 2014-04-10 |
| 2014-01-13 | 9.75M shares 10-Q · filed 2014-01-14 |
| 2013-11-25 | 7.95M shares 10-K · filed 2013-11-27 |
| 2013-07-17 | 7.90M shares 10-Q · filed 2013-07-17 |
| 2013-04-10 | 7.22M shares 10-Q · filed 2013-04-11 |
| 2012-12-19 | 86.51M shares 10-Q · filed 2012-12-26 |
| 2012-12-06 | 86.51M shares 10-K · filed 2012-12-12 |
| 2012-07-11 | 70.45M shares 10-Q · filed 2012-07-12 |
| 2012-04-03 | 70.32M shares 10-Q · filed 2012-04-04 |
| 2012-01-10 | 70.19M shares 10-Q · filed 2012-01-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |